BHUBANESWAR, India, Oct. 7, 2024 /PRNewswire/ -- The President of the International Volleyball Federation (FIVB) Dr. Ary S. Graça was conferred the prestigious KISS Humanitarian Award 2020 on 4th October 2024 in recognition of his outstanding contribution towards the promotion of the game across the world. The KISS Humanitarian Award is a prestigious annual international honor conferred by the Kalinga Institute of Social Sciences (KISS) in Bhubaneswar, India. Conceptualized by visionary humanitarian and educationist Prof. Achyuta Samanta, Founder of KIIT and KISS, the award recognizes individuals for their exemplary and distinguished service to humanity worldwide.
The award was given away by the Governor of Odisha Raghubar Das in the presence of Deputy Chief Minister Kanak Vardhan Singh Deo. Although the award was announced in 2020, Dr. Graça was unable to receive it at that time due to the COVID-19 pandemic.
The Governor, in his speech, admired Dr. Graca's commitment to promoting volleyball throughout the world and bringing a positive change to society through the game. He said that the KISS Humanitarian Award reflects humanitarian and social values, encouraging individuals working in these fields worldwide to strive for further achievements. Mr Singh Deo, on the other hand, congratulated Dr. Graça for the award and lauded the efforts of Dr. Samanta for instituting the KISS humanitarian award.
During the event, Dr. Achyuta Samanta, the Founder of KIIT and KISS and former president of the Volleyball Federation of India, provided insights about Dr. Graça, noting that the 81-year-old Brazilian has served as the FIVB President for over 12 years. FIVB is the largest sports federation in the world, with 222-member nations. Samanta expressed pride in Dr. Graça receiving the KISS Humanitarian Award, highlighting it as a symbol of recognition for efforts made in humanitarian and social fields globally.
Dr. Graça had always admired Dr. Samanta's efforts to develop volleyball in the country and came to India for the first time specifically to receive the award. Dr. Graça said his primary aim through the game is to bring peace and harmony across the world. "My passion is to continue to cherish the values of empowerment, teamwork, and opportunities and serve the world through volleyball".
Notably, the KISS Humanitarian Award has previously been conferred upon various distinguished global leaders, Nobel laureates, and notable figures across multiple fields, underscoring its international significance and prestige.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
FIVB President Dr. Ary S. Graça Conferred KISS Humanitarian Award
MILAN, Oct. 7, 2024 /PRNewswire/ -- NTC, an international pharmaceutical company headquartered in Milan, Italy, announced today to have embraced a strategic partnership with Silgan Dispensing Systems, a global leading supplier of dispensing solutions in healthcare to commercialize a set of new NTC proprietary eye drops with the innovative Silgan technology Iridyaâ„¢, a new preservative free multidose eye dropper.
"Thanks to Iridyaâ„¢, we improve our innovative dry eye portfolio, pursuing maximum patient satisfaction and compliance", says Marcello Selvaggio, NTC Global Head Ophthalmology. "We launched the Imperial product line for dry eye offering to our partners a solution that blends the benefits of the other main multidose preservative free devices into one, the Imperial product line, based on our innovative product range".
NTC is going to present the Imperial line during CPhI in Milan, supporting with evidence the innovation of this device characterized by exceptional drop control for precise dosing, elongated tip for a greater accuracy in instillation, and advanced ergonomics to assure a low squeeze force bottle.
"We are excited to unleash the potential of the Iridya technology of a leading company like Silgan," – says Riccardo Carbucicchio, CEO of NTC - "The NTC Imperial line is a further proof of NTC's focus on unmet medical needs and its continuous search for innovative solutions. The Imperial products will enhance the patient experience in dry eye and are designed to stay on the side of the patient".
"We are excited and proud to have partnered with NTC, a leading company in the ophthalmic market that has placed its trust in Silgan Dispensing Systems and our product Iridyaâ„¢" - says Eric Demaris, Commercial Director EMEA Silgan Dispensing Healthcare. "We are certain that this collaboration will allow us to offer increasingly better solutions in the treatment of dry eye diseases based on Iridya preservative-free technology. Thanks to Iridyaâ„¢ proven formula protection, broad compatibility, output accuracy and comfortable ergonomics, we can ensure brand owners deliver more secure dosing, drop after drop, to their patients."
NTC research makes innovation accessible to everyone and enhances product potential by looking at people's daily care needs and application habits.
The Imperial product line is a testimony to NTC's historical vocation for innovation to improve the experience and practice of care.
NTC offers products that increase people's participation and control, thus enhancing better compliance.
About NTC
A pharmaceutical company headquartered in Milan - Italy, with distributors and partners in more than 100 countries, engaged in research, development, registration, and commercialization of drugs, medical devices, and food supplements in ophthalmology, and other therapeutic areas including pediatrics, gynecology, and gastroenterology. NTC offers more than 200 partners innovative and highquality standard pharmaceutical products. For more information, please visit www.ntcpharma.com
About Silgan Dispensing Systems
Silgan Dispensing is a global leader in the design, development and distribution of highly engineered pumps and sprayers in the Home, Health and Beauty markets creating dispensing solutions for some of the world's most iconic brands.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
NTC Launches Imperial, the new eye drops product line on THE PATIENT'S SIDE
